The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Hybrid broccoli

    The Financial Times reports, “A new hybrid variety richer in chemicals linked to a reduced risk of cancer and cardiovascular problems goes on sale on Tuesday” in the UK.

    Here’s what we know.

    • The hybrid broccoli (called Beneforté) was developed by British academics and involves no genetic modification.
    • Beneforté contains up to 3 times the levels of glucoraphanin, which some research suggests lowers the risk of aggressive prostate cancer and heart disease.
    • The new broccoli will cost £1.49 ($2.00) each, compared with £1 ($1.32) for existing varieties.

    The bottom line?

    More on the history of functional foods and what distinguishes them from nutraceuticals can be found here.

    10/4/11 21:27 JR

    Leave a Comment

    You must be logged in to post a comment.